HAMILTON GLB.OPP.LS-0001

Research HAMILTON GLB.OPP.LS-0001 (5DS) on Bullrun: market cap EUR 24.13M, P/E 0.0, dividend yield 9.0%. Explore financials, valuation history, model signals, and stock context.

Key Metrics

Valuation Snapshot

latest market cap is EUR 24.13M; P/E is 0.0; dividend yield is 9.0%.

Peer valuation comparison

Latest P/E is 0.04x versus a Financial Services sector median of 13.84x (99.7% below).

Latest dividend yield is 8.96% versus a Financial Services sector median of 3.86% (132.4% above).

Five-year financial history

YearRevenueNet incomeFree cash flowGross marginDiluted EPSCashTotal debtEquity
FY2025EUR 37.32KEUR 5.77M-EUR 1.72Mn/a918EUR 144.23KEUR 3.10MEUR 28.12M
FY2024EUR 229.03K-EUR 304.55K-EUR 712.80Kn/a-69EUR 1.00MEUR 3.13MEUR 22.37M
FY2023EUR 274.59K-EUR 781.56K-EUR 655.34Kn/a-1.9EUR 853.25KEUR 0EUR 13.55M
FY2022EUR 282.82KEUR 1.34M-EUR 966.90Kn/a3.26EUR 1.95Mn/aEUR 14.39M

Valuation history

YearSnapshot dateMarket capP/EDividend yieldAnnual dividend/share
20262026-08-18EUR 24.13M0.09.0%3.44

Dividend history

Latest trailing dividend snapshot: annual dividend/share 3.44 EUR, yield 9.0%.

About HAMILTON GLB.OPP.LS-0001

Hamilton Global Opportunities PLC, an investment holding company, focuses on providing capital solutions to growth stage companies in the United States. The company operates a tech-enabled, alternative lending platform specialized in providing financing for the pharmacy sector; and a trading platform for various exchanges.

Related stock research

Other Financial Services stocks

Frequently asked questions

What is HAMILTON GLB.OPP.LS-0001's market cap?

HAMILTON GLB.OPP.LS-0001's market capitalization is EUR 24.13M.

What is HAMILTON GLB.OPP.LS-0001's P/E ratio?

HAMILTON GLB.OPP.LS-0001's price-to-earnings (P/E) ratio is 0.0.

Does HAMILTON GLB.OPP.LS-0001 pay a dividend?

HAMILTON GLB.OPP.LS-0001 has a dividend yield of 9.0%.

What does HAMILTON GLB.OPP.LS-0001 do?

Hamilton Global Opportunities PLC, an investment holding company, focuses on providing capital solutions to growth stage companies in the United States. The company operates a tech-enabled, alternative lending platform specialized in providing financing for the pharmacy sector; and a trading platform for various exchanges. It also offers nanotechnology for light control and advanced driver assistance systems, as well as operates a platform that provides a range of investment banking services for institutional finance.